Sachs David C.
Insider CIK 1848899 · IBRX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-02-22 | 2026-02-24 | 40,650 | — | $0 | 40,651 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-02-22 | 2026-02-24 | 40,650 | — | $0 | 320,825 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2026-02-22 | 2026-02-24 | 20,682 | $8.70 | $179.9K | 300,143 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-02-10 | 2026-02-12 | 82,236 | — | $0 | 164,474 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2026-02-10 | 2026-02-12 | 42,643 | $6.93 | $295.5K | 280,175 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-02-10 | 2026-02-12 | 82,236 | — | $0 | 322,818 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 30,397 | — | $0 | 45,602 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 30,397 | — | $0 | 256,017 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2025-12-31 | 2026-01-05 | 15,435 | $1.98 | $30.6K | 240,582 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2025-02-22 | 2025-02-25 | 40,650 | — | $0 | 81,301 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2025-02-22 | 2025-02-25 | 15,860 | $3.42 | $54.2K | 225,620 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2025-02-22 | 2025-02-25 | 40,650 | — | $0 | 241,480 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2025-02-10 | 2025-02-12 | 246,710 | — | $0 | 246,710 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2025-02-10 | 2025-02-12 | 843,750 | — | $0 | 843,750 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 30,397 | — | $0 | 75,999 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2024-12-31 | 2025-01-03 | 15,405 | $2.56 | $39.4K | 200,830 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 30,397 | — | $0 | 216,235 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 121,951 | — | $0 | 121,951 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 424,390 | — | $0 | 424,390 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2024-01-31 | 2024-02-02 | 70,745 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2024-01-31 | 2024-02-02 | 70,745 | — | $0 | 212,673 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2024-01-31 | 2024-02-02 | 26,835 | $3.36 | $90.2K | 185,838 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2023-12-31 | 2024-01-03 | 30,397 | — | $0 | 106,396 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2023-12-31 | 2024-01-03 | 30,397 | — | $0 | 152,439 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2023-12-31 | 2024-01-03 | 10,511 | $5.02 | $52.8K | 141,928 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2023-09-01 | 2023-09-06 | 70,744 | — | $0 | 70,745 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2023-09-01 | 2023-09-06 | 70,744 | — | $0 | 122,042 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2023-08-25 | 2023-08-28 | 141,489 | — | $0 | 141,489 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2022-12-31 | 2023-01-04 | 7,598 | — | $0 | 136,793 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2022-12-31 | 2023-01-04 | 7,598 | — | $0 | 51,298 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2022-03-23 | 2022-03-25 | 125,000 | — | $0 | 125,000 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2022-03-23 | 2022-03-25 | 125,000 | — | $0 | 125,000 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2021-12-09 | 2021-12-13 | 17,242 | — | $0 | 144,391 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2021-12-09 | 2021-12-13 | 17,242 | — | $0 | 43,700 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2021-09-09 | 2021-09-13 | 7,598 | — | $0 | 161,633 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2021-09-09 | 2021-09-13 | 7,598 | — | $0 | 26,458 | SEC↗ |